Event Date/Time: May 12, 2012
End Date/Time: May 12, 2012
This symposium is intended to improve care of patients with hematological malignancies by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of hematological malignancies, this symposium will focus on individualized therapy based on emerging agents currently in development, supportive care therapy and cost and reimbursement issues. The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. In-depth discussion of novel agents at various stages of clinical development will be given significant focus.